{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:19:22Z","timestamp":1787761162481,"version":"build-2784847793"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Vessels, Thrombosis &amp; Hemostasis"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bvth.2026.100193","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:13:51Z","timestamp":1783937631000},"page":"100193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Doxycycline for epistaxis in hereditary hemorrhagic telangiectasia: genotype-stratified outcomes"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6502-7081","authenticated-orcid":false,"given":"Jinelis","family":"Santiago-Beniquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0577-1635","authenticated-orcid":false,"given":"Avraham","family":"Adelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0757-7790","authenticated-orcid":false,"given":"Eunice","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1634-7650","authenticated-orcid":false,"given":"Anil","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3744-0451","authenticated-orcid":false,"given":"Nikita","family":"Chapurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Eagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ataya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9552-475X","authenticated-orcid":false,"given":"Marc","family":"Zumberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K.","family":"Mulligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1533-1665","authenticated-orcid":false,"given":"Brian C.","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4729-028X","authenticated-orcid":false,"given":"Jeb M.","family":"Justice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bvth.2026.100193_bib1","doi-asserted-by":"crossref","DOI":"10.1172\/JCI176379","article-title":"Hereditary hemorrhagic telangiectasia: from signaling insights to therapeutic advances","volume":"134","author":"Al Tabosh","year":"2024","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.bvth.2026.100193_bib2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/1358863X231151731","article-title":"Multidisciplinary coordinated care of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease)","volume":"28","author":"Alkhalid","year":"2023","journal-title":"Vasc Med"},{"issue":"7","key":"10.1016\/j.bvth.2026.100193_bib3","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1148\/rg.2021210100","article-title":"Imaging manifestations and interventional treatments for hereditary hemorrhagic telangiectasia","volume":"41","author":"Kolarich","year":"2021","journal-title":"Radiographics"},{"issue":"12","key":"10.1016\/j.bvth.2026.100193_bib4","doi-asserted-by":"crossref","first-page":"989","DOI":"10.7326\/M20-1443","article-title":"Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia","volume":"173","author":"Faughnan","year":"2020","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.bvth.2026.100193_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.otc.2017.09.017","article-title":"Hereditary hemorrhagic telangiectasia","volume":"51","author":"K\u00fchnel","year":"2018","journal-title":"Otolaryngol Clin North Am"},{"issue":"9","key":"10.1016\/j.bvth.2026.100193_bib6","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3324\/haematol.2018.193003","article-title":"Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist\u2019s perspective","volume":"103","author":"Kritharis","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.bvth.2026.100193_bib7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.thromres.2023.04.017","article-title":"Anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia: A scoping review","volume":"226","author":"Zhang","year":"2023","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.bvth.2026.100193_bib8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.anl.2023.11.002","article-title":"Understanding hereditary hemorrhagic telangiectasia: from genetic anomalies to systemic manifestations, quality of life, and epistaxis management-Exploring the otolaryngologist\u2019s integral role","volume":"51","author":"Hayama","year":"2024","journal-title":"Auris Nasus Larynx"},{"issue":"1","key":"10.1016\/j.bvth.2026.100193_bib9","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1167\/iovs.12-10323","article-title":"Doxycycline-mediated inhibition of corneal angiogenesis: an MMP-independent mechanism","volume":"54","author":"Su","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.bvth.2026.100193_bib10","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1167\/iovs.08-3174","article-title":"Doxycycline-mediated inhibition of choroidal neovascularization","volume":"50","author":"Samtani","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.bvth.2026.100193_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvir.2014.12.306","article-title":"Novel pharmacological therapy for the treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia","volume":"26","author":"Jordan","year":"2015","journal-title":"J Vasc Interv Radiol"},{"issue":"5","key":"10.1016\/j.bvth.2026.100193_bib12","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/jth.15662","article-title":"North American study for the treatment of recurrent epistaxis with doxycycline: the NOSTRIL trial","volume":"20","author":"McWilliams","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.bvth.2026.100193_bib13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s13023-022-02539-8","article-title":"Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia","volume":"17","author":"Thompson","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.1016\/j.bvth.2026.100193_bib14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/03009734.2018.1483452","article-title":"Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler\u2019s Disease, Uppsala University Hospital","volume":"123","author":"Karlsson","year":"2018","journal-title":"Ups J Med Sci"},{"issue":"13","key":"10.1016\/j.bvth.2026.100193_bib15","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.3390\/jcm14134409","article-title":"Genotype-phenotype relationship in hereditary hemorrhagic telangiectasia: quality of life and cardiovascular risk evaluation","volume":"14","author":"Viteri-No\u00ebl","year":"2025","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.bvth.2026.100193_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","article-title":"Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)","volume":"91","author":"Shovlin","year":"2000","journal-title":"Am J Med Genet"},{"issue":"4","key":"10.1016\/j.bvth.2026.100193_bib17","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/lary.20818","article-title":"An epistaxis severity score for hereditary hemorrhagic telangiectasia","volume":"120","author":"Hoag","year":"2010","journal-title":"Laryngoscope"},{"issue":"11","key":"10.1016\/j.bvth.2026.100193_bib18","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/jamaoto.2020.3040","article-title":"Development and validation of the nasal outcome score for epistaxis in hereditary hemorrhagic telangiectasia (NOSE HHT)","volume":"146","author":"Peterson","year":"2020","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"11","key":"10.1016\/j.bvth.2026.100193_bib19","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/alr.21374","article-title":"The effects of epistaxis on health-related quality of life in patients with hereditary hemorrhagic telangiectasia","volume":"4","author":"Merlo","year":"2014","journal-title":"Int Forum Allergy Rhinol"},{"issue":"12","key":"10.1016\/j.bvth.2026.100193_bib20","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s11882-023-01116-8","article-title":"Treatments of epistaxis in hereditary hemorrhagic telangiectasia: systematic review and network meta-analysis","volume":"23","author":"Chitsuthipakorn","year":"2023","journal-title":"Curr Allergy Asthma Rep"},{"issue":"7","key":"10.1016\/j.bvth.2026.100193_bib21","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00775-023-02018-w","article-title":"The formation of Fe3+-doxycycline complex is pH dependent: implications to doxycycline bioavailability","volume":"28","author":"Kora\u0107 Ja\u010di\u0107","year":"2023","journal-title":"J Biol Inorg Chem"},{"issue":"2","key":"10.1016\/j.bvth.2026.100193_bib22","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jac\/dkl224","article-title":"Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines","volume":"58","author":"Agwuh","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.bvth.2026.100193_bib24","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-0042-1743467","article-title":"Systemic antiangiogenic therapies for bleeding in hereditary hemorrhagic telangiectasia: a practical, evidence-based guide for clinicians","volume":"48","author":"Al-Samkari","year":"2022","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"10.1016\/j.bvth.2026.100193_bib25","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/0003489419826139","article-title":"Bevacizumab as treatment for epistaxis in hereditary hemorrhagic telangiectasia: a literature review","volume":"128","author":"Kini","year":"2019","journal-title":"Ann Otol Rhinol Laryngol"}],"container-title":["Blood Vessels, Thrombosis &amp; Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327226000586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327226000586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:25:27Z","timestamp":1787757927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950327226000586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2950327226000586"],"URL":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100193","relation":{},"ISSN":["2950-3272"],"issn-type":[{"value":"2950-3272","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Doxycycline for epistaxis in hereditary hemorrhagic telangiectasia: genotype-stratified outcomes","name":"articletitle","label":"Article Title"},{"value":"Blood Vessels, Thrombosis & Hemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100193"}}